Bionano Genomics Stock Investor Sentiment
| BNGO Stock | USD 0.79 0.03 4.00% |
About 60% of all Bionano Genomics' investors are looking to take a long position. The analysis of overall sentiment of trading Bionano Genomics stock suggests that some investors are interested at this time. Bionano Genomics' investor sentiment overview provides quick insight into current market opportunities from investing in Bionano Genomics. The current market sentiment, together with Bionano Genomics' historical and current headlines, can help investors time the market. In addition, many technical investors use Bionano Genomics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
60
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bionano Genomics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bionano Genomics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Bionano Genomics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bionano daily returns and investor perception about the current price of Bionano Genomics as well as its diversification or hedging effects on your existing portfolios.
Bionano Historical Sentiment
Although Bionano Genomics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bionano, such as negative comments on social media and news outlets, may cause fear in the market and push Bionano Genomics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bionano.
Bionano |
Bionano Genomics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Bionano Genomics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Bionano Genomics that are available to investors today. That information is available publicly through Bionano media outlets and privately through word of mouth or via Bionano internal channels. However, regardless of the origin, that massive amount of Bionano data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bionano Genomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bionano Genomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bionano Genomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bionano Genomics alpha.
Bionano Genomics Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | 7 Penny Stocks to Buy on the Dip February 2024 - Yahoo Finance | 02/07/2024 |
2 | Disposition of 402 shares by Jonathan Dixon of Bionano Genomics at 1.27 subject to Rule 16b-3 | 02/15/2024 |
3 | Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 | 03/05/2024 |
4 | Bionano Genomics Q4 2023 Earnings Call Transcript | 03/06/2024 |
5 | Bionano Genomics, Inc. Q4 2023 Earnings Call Transcript | 03/07/2024 |
6 | Do Traders Think BioNano Genomics Inc Can Turn Around Thursday - InvestorsObserver | 03/14/2024 |
7 | BioNano Genomics Inc is higher by 2.86 percent Thursday In Premarket Trading - InvestorsObserver | 03/21/2024 |
8 | BioNano Genomics Inc is lower by 0.96 percent Monday In Premarket Trading - InvestorsObserver | 03/25/2024 |
9 | Disposition of 1081 shares by Chaubey Alka of Bionano Genomics at 1.27 subject to Rule 16b-3 | 04/03/2024 |
10 | Bionano Announces 10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | 04/04/2024 |
11 | Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole... | 04/11/2024 |
Check out Bionano Genomics Hype Analysis, Bionano Genomics Correlation and Bionano Genomics Performance. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.Note that the Bionano Genomics information on this page should be used as a complementary analysis to other Bionano Genomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Bionano Stock analysis
When running Bionano Genomics' price analysis, check to measure Bionano Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionano Genomics is operating at the current time. Most of Bionano Genomics' value examination focuses on studying past and present price action to predict the probability of Bionano Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionano Genomics' price. Additionally, you may evaluate how the addition of Bionano Genomics to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Bionano Genomics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.81) | Revenue Per Share 1.058 | Quarterly Revenue Growth 0.305 | Return On Assets (0.33) | Return On Equity (1.35) |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.